Boardroom Alpha
10-K primary document
AEMD · Annual Report (Form 10-K) · Filed June 10, 2026

Aethlon Medical Inc10-K exhibit

aethlon_ex2301.htm

EXHIBIT 23.1

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

We consent to the incorporation by reference in the Registration Statements on Form S-8 (File Nos. 333-267504, and 333-248820), Form S-1 (File Nos. 333-234712, 333-201334, 333-219589, 333-278188, 333-292598, and 333-289745), and Form S-3 (File No. 333-292405) of Aethlon Medical, Inc. (the “Company”) of our report dated June 10, 2026, relating to the consolidated financial statements as of March 31, 2026 and 2025 and for each of the two years in the period ended March 31, 2026, which appears in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2026.

 

Our report includes an explanatory paragraph expressing substantial doubt regarding the Company’s ability to continue as a going concern.

 

 

/s/ Haskell & White LLP

 

HASKELL & WHITE LLP

 

 

Irvine, California

June 10, 2026

 

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer